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Objectives: To characterize the temporal pattern of a panel of 
blood and urinary biomarkers in an animal model of fecal peritoni-
tis and recovery.
Design: Prospective observational animal study.
Setting: University research laboratory.
Subjects: Male Wistar rats.
Interventions: A fluid-resuscitated, long-term (3 d) rat model of 
sepsis (fecal peritonitis) and recovery was used to understand 
the temporal association of sepsis biomarkers in relation to sys-
temic hemodynamics, inflammation, and renal function. At pre-
defined time points (3, 6, 12, 24, 48, 72 hr), animals (≥ 6 per 
group) underwent echocardiography, blood and urine sampling, 
and had kidneys taken for histological analysis. Comparison was 
made against sham-operated controls and naïve animals.
Measurements and Main Results: The systemic proinflammatory 
response was maximal at 6 hours, corresponding with the nadir 
of stroke volume. Serum creatinine peaked late (24 hr), when clini-
cal recovery was imminent. Histological evidence of tubular injury 
and cell death was minimal. After a recovery period, all biomark-
ers returned to levels approaching those observed in sham ani-
mals. Apart from urine clusterin and interleukin-18, all other urinary 
biomarkers were elevated at earlier time points compared with 
serum creatinine. Urine neutrophil gelatinase-associated lipocalin 
was the most sensitive marker among those studied, rising from 
3 hours. While serum creatinine fell at 12 hours, serum cystatin C 
increased, suggestive of decreased creatinine production.
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Conclusions: Novel information is reported on the temporal profile of 
a panel of renal biomarkers in sepsis in the context of systemic and 
renal inflammation and recovery. Insight into the pathophysiology of 
acute kidney injury is gleaned from the temporal change markers 
of renal injury (urine neutrophil gelatinase-associated lipocalin, kid-
ney injury molecule-1, calbindin), followed by a marker of cell cycle 
arrest (urine insulin-like growth factor-binding protein 7) and, finally, 
by functional markers of filtration (serum creatinine and cystatin C). 
These clinically relevant findings should have significant influence 
on future clinical testing. (Crit Care Med 2017; 45:e821–e830)
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Sepsis is the underlying cause in half the cases of acute kidney injury (AKI) (1). Up to 5% of total ICU admissions require renal replacement therapy for AKI and a third of them die (1, 
2). Despite the clinical impact of septic AKI management is limited 
to supportive care. The current lack of a sensitive marker of early 
parenchymal kidney injury reduces the window of opportunity 
for early effective intervention to prevent renal dysfunction and 
failure. Numerous blood and urine markers of renal injury/dys-
function are being promoted but, at present, remain poorly char-
acterized. Few studies have investigated the utility of biomarkers 
in predicting recovery from AKI (3). A complementary panel of 
markers will likely enhance interpretation of this dynamic process, 
although studies in septic patients are confounded by an inability 
to precisely time the onset of sepsis. Thus, the temporal relation-
ship of these biomarkers to the onset, progression, and recovery of 
renal dysfunction and injury is unknown. Serial measurements of 
a panel of renal biomarkers in a well-characterized animal model 
with a defined onset of polymicrobial sepsis followed by recovery 
will provide invaluable information translatable to the patient.
Animal models of sepsis offer the advantage of knowing 
precisely when “time zero” occurs and also allow control of 
volume status and other conditions in a relatively homogenous 
population. However, to be representative of the human condi-
tion, they must simulate many of the physiologic and patho-
logic aspects of sepsis, including a proper infectious insult, an 
adequate duration of study, and fluid resuscitation to avoid 
the consequences of untreated hypovolemia leading to organ 
hypoperfusion. We used a clinically relevant and well-charac-
terized model of sepsis and recovery to define parallel changes 
in global hemodynamics, biochemistry, renal histology, serum 
cytokines, and a panel of renal biomarkers (4, 5).
MATERIALS AND METHODS
In Vivo Experiments
Male Wistar rats (Charles River, Margate, Kent, United King-
dom) weighing 300–375 g were used. Experiments were per-
formed under a Home Office Project License (PPL 70/7029) 
and local University College London Ethics Committee 
approval. The rats were housed in cages of six on a 12-12–hour 
light-dark cycle. Six time points were selected to represent early 
(3, 6, 12 hr), established (24 hr), and recovery (48 and 72 hr) 
phases of sepsis.
All invasive and imaging techniques were performed under a 
brief period of isoflurane anesthesia with the animal breathing 
spontaneously, as described previously (4, 5). Following tunneled 
internal jugular line placement, rats were placed in individual cages 
mounted on the tether/swivel system to secure the IV catheter and 
allow unimpeded movement with free access to food and water. 
The reasons for tunneled central venous catheter (CVC) insertion 
are two-fold; first, to prevent the line from being pulled out by the 
animal and thus enable ongoing fluid resuscitation and second, to 
reduce the risk of CVC-related infection. At 24-hour postinstru-
mentation, sepsis was induced by intraperitoneal injection of fecal 
slurry (see Appendix for more detail). This was not performed in 
sham animals to prevent inadvertent bowel perforation.
Antibiotics were not administered to avoid any confound-
ing drug-induced nephrotoxicity. The optimal volume and 
rate of fluid administration (with 1:1 mix of 5% glucose and 
Hartmann’s solution) to maintain intravascular volume based 
on echo variables have been previously determined (4). Sham 
animals received a similar fluid regimen.
Echocardiography was performed prior to each fluid bolus 
and at the terminal time point as previously described (4, 5). At 
the terminal time point, a carotid arterial catheter was inserted 
under isoflurane anesthesia with the animals breathing spon-
taneously. Blood gas analysis was performed using 0.2 mL 
arterial blood taken into heparinized capillary tubes (ABL-70 
analyzer, Radiometer, Copenhagen, Denmark).
A laparotomy incision was made and a 22-gauge needle used 
to aspirate urine via bladder puncture. The left kidney was isolated 
and the upper pole placed into formalin and the rest snap-frozen 
in liquid nitrogen. Cardiac puncture was then performed to obtain 
blood which was placed in a heparinized tube and centrifuged at 
6,500 rpm for 10 minutes. The serum was siphoned off, aliquots 
taken, snap-frozen in liquid nitrogen, and stored at –80°C.
Serum and Tissue Sample Measurements
DuoSet enzyme-linked immunosorbent assay (ELISA) kits 
(R&D Systems, Minneapolis, MN; BD Biosciences, Oxford, 
Oxon, United Kingdom) were used to assess serum cytokine 
levels according to the manufacturers’ instructions. Absor-
bance was read at 450 nm using a spectrophotometric ELISA 
plate reader (Anthos HTII; Anthos Labtec, Salzburg, Austria).
MILLIPLEX
MAP
 multianalyte panels (Merck Millipore, 
Watford, Herts, United Kingdom) were used for simultaneous 
detection and quantification of eight biomarkers and cyto-
kines/chemokine in rat urine, including neutrophil gelatinase-
associated lipocalin (NGAL), cystatin C, interleukin (IL)-18, 
monocyte chemotactic protein (MCP)-1, clusterin, calbin-
din, osteopontin, and kidney injury molecule (KIM)-1. The 
same technique was used to determine serum levels of IL-18. 
Assays were performed according to the manufacturer’s pro-
tocols. The plate was read on a Bio-Plex 200 multiplex system 
(Bio-Rad, Hemel Hempstead, Herts, United Kingdom). Urine 
tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-
like growth factor-binding protein 7 (IGFBP7) were analyzed 
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by ELISA as described previously (6). Renal function (serum 
creatinine) was analyzed using the Jaffe assay by the Clinical 
Pathology laboratory at the Royal Free Hospital, London, 
United Kingdom. Where urine biomarkers were analyzed, 
matched creatinine values were used.
Immunohistochemistry
Kidneys were fixed for 24–72 hours in formalin, transferred to 
70% ethanol, and embedded in paraffin. Sections were then cut 
into 5 µm slices and mounted onto glass slides. For all histolog-
ical analyses, sections were examined using an Olympus B×4 
microscope (Olympus Optical, London, United Kingdom) at 
×20 magnification. For assessment of tubular injury (tubular 
dilatation, brush border loss, and tubular cast formation), sec-
tions were stained with Periodic acid-Schiff. Ten random fields 
of view of the cortex were analyzed for each section at ×20 mag-
nification under a light microscope. Apoptosis was identified 
by DNA fragments in situ using the terminal deoxyribonucle-
otidyl transferase (TdT)-mediated biotin-16-2-deoxyuridine 
5'-triphosphate (dUTP) nick-end labeling (terminal deoxynu-
cleotidyl transferase dUTP nick-end labeling [TUNEL] assay) 
using the TACS TdT In Situ Apoptosis Detection Kit (R&D 
Systems, Abingdon, Oxford, United Kingdom). The total num-
ber of apoptotic bodies per ×20 field was counted manually 
and an average taken for each group. A total of three slides for 
the septic groups (with at least one from the poor prognosis 
subgroup) and two from the naïve groups from time points 6, 
12, 24, 48, and 72 hours were selected.
Statistics
Analyses were performed using SPSS (IBM SPSS Statistics, Ver-
sion 22.0; IBM Corp, Armonk, NY), and graphs drawn using 
Graphpad Prism Version 5.0d (GraphPad Software, La Jolla, 
CA). Continuous variables are presented as median (inter-
quartile range). Differences in continuous variables between 
groups were compared using Mann-Whitney U test. Pearson’s 
correlation was performed to assess the degree of correla-
tion between serum and urine levels of biomarkers (cystatin 
C, NGAL, IL-18, and MCP-1). A p value of less than 0.05 was 
taken as statistically significant.
RESULTS
Baseline measurements (weight, temperature, heart rate 
[HR], stroke volume [SV], cardiac output [CO]) were simi-
lar between groups. In total, 19 animals died (20%, as per the 
severity of the model). All deaths occurred after the 12-hour 
time point and before the 48-hour time point. These animals 
were not used for biomarker/biochemistry analyses. The sam-
pling time (involving kill of the animals) was randomized. All 
animals intended for sampling at early time points survived, 
whereas some of the animals intended for sampling at a late 
time point succumbed prior to reaching this time point.
Physiologic Markers
At 3-hour postinduction of sepsis, there was a significant fall 
in stroke volume and cardiac output (Fig. 1). Septic animals 
mounted a significant tachycardia by 6 hours, which persisted 
at 24 hours. This paralleled the increase in core body tempera-
ture. By 48 hours, SV, CO, HR, and core temperature normalized 
among septic animals, and these remained stable until 72 hours.
Biochemical Markers
There was an early peak (3 hr) in serum urea and creatinine in 
septic animals (Fig. 2). Alongside the significant rise in hema-
tocrit at 6 hours, this suggests intravascular volume depletion, 
despite aggressive fluid loading. Once fluid resuscitation com-
menced (from 2 hr), there was a progressive fall in serum urea and 
Figure 1. Seventy-two–hr characterization of sepsis and recovery 
phases—systemic variables. Septic animals develop a tachycardia, fall in 
stroke volume (SV) and fever early (3–6 hr), which resolves from 24 hr to 
reach baseline values at 72 hr. Points and whiskers represent median and 
interquartile range, respectively. *p < 0.05 sham vs sepsis; (*)p = 0.05–
0.06 sham vs sepsis. CO = cardiac output, HR = heart rate.
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Figure 2. Seventy-two–hr characterization of sepsis and recovery phases—biochemistry. Biochemical changes occur from 3 hr. Apart from serum urea, 
changes are maximal at 24 hr followed by recovery to baseline values at 72 hr. The early rise in urea, creatinine, and lactate is corrected after fluid 
resuscitation, demonstrating early hemoconcentration. Points and whiskers represent median and interquartile range, respectively. *p < 0.05 sham vs 
sepsis; (*)p = 0.05–0.06 sham vs sepsis.
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creatinine that normalized by 6–12 hours. By 24 hours, serum 
urea and creatinine were significantly elevated. The peak serum 
creatinine level (30 µmol/L) was 1.5-fold above that of baseline. 
The increases in arterial lactate levels were phasic, with a rise at 3 
hours, normalization at 6 hours, a further peak at 24 hours and 
then a subsequent fall. The arterial base excess fell in the septic 
animals but normalized by 48 hours. The rise in serum cystatin 
C approached statistical significance by 12 hours and remained 
elevated at 24 hours. Compared with sham animals, serum albu-
min and glucose fell in the septic animals, reaching a nadir at 24 
hours. This change was more pronounced in the septic rats com-
pared with sham-operated rats. Recovery occurred by 72 hours.
Serum Cytokines
Most proinflammatory cytokines were significantly elevated by 3 
hours, including IL-1β, IL-6, MCP-1, and NGAL (Fig. 3). Apart 
from IL-6, all these cytokines remained elevated for at least 24 
hours. The anti-inflammatory cytokine IL-10 was also signifi-
cantly elevated at 3 hours. The earliest cytokine to peak was IL-1β 
at 3 hours, which remained elevated until 24 hours. Serum MCP-1 
levels followed a similar pattern to IL-1β. IL-6, in contrast, peaked 
at 6 hours and fell sharply thereafter, to reach baseline levels by 48 
hours. There was a trend toward an elevated IL-18 at 48 hours.
Urine Biomarkers
Ten different urine biomarkers (KIM-1, NGAL, TIMP-2, IGFBP-
7, IL-18, MCP-1, calbindin, clusterin, osteopontin, cystatin C) 
were measured in addition to serum biomarkers of renal function 
(serum urea, creatinine, and cystatin C) (Fig. 4). All urine bio-
markers related to tubular cell injury, apart from TIMP-2, were 
significantly altered to varied degrees and with different kinetics. 
All biomarkers returned to levels approaching those observed in 
Figure 3. Characterization of sepsis and recovery phases—serum cytokines. The proinflammatory cytokine kinetic pattern is variable. Interleukin (IL)-
1β and IL-6 rise early (3 hr) and remain elevated until 24 hr. The anti-inflammatory cytokine IL-10 begins to rise by 3 hr but remains elevated through to 
resolution. Points and whiskers represent median and interquartile range, respectively. *p < 0.05 sham vs sepsis; (*)p = 0.05–0.06 sham vs sepsis.  
MCP = monocyte chemotactic protein, NGAL = neutrophil gelatinase-associated lipocalin.
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Figure 4. Seventy-two–hr characterization—urine biomarkers. Urine neutrophil gelatinase-associated lipocalin (NGAL) was the most sensitive marker, 
rising from 3 to 24 hr. Other biomarkers were also elevated before the rise in serum creatinine, though the magnitude of their rise was much less compared 
with NGAL. Urine interleukin (IL)-18 was not elevated in septic animals. Points and whiskers represent median and interquartile range, respectively. 
*p < 0.05 sham vs sepsis; (*)p = 0.05–0.06 sham vs sepsis. IGFPB-7 = insulin-like growth factor-binding protein 7, MCP = monocyte chemotactic protein.
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sham animals with clinical recovery. Apart from urine osteopon-
tin and IL-18, all other urine biomarkers were elevated and at an 
earlier time point to serum creatinine (at 24 hr).
Urine NGAL was the earliest biomarker to rise (3 hr) with 
a sustained peak lasting from 24–48 hours. Urine KIM-1 and 
calbindin peaked at 6 hours, and fell thereafter, with calbindin 
reaching baseline values by 24 hours and KIM-1 by 72 hours. 
Although urine clusterin rose early (3 hr), it lacked discrimina-
tory values due to variability in values. Urine cystatin C, a marker 
of glomerular filtration rate (GFR) and intact tubular reabsorp-
tion, was raised between 24 and 48 hours in septic animals.
Urine IGFBP-7, a marker of cell cycle arrest, was signifi-
cantly elevated at 12 hours. This followed the rise seen in tubu-
lar injury markers but preceded the rise in functional markers 
of filtration (i.e., serum creatinine and cystatin C). TIMP-2, 
another cell cycle arrest marker, was also elevated at 12 hours, 
but only approached statistical significance. The fall in uri-
nary levels of KIM-1 and calbindin at 24 hours seems to pre-
dict renal recovery. Although this time point coincided with a 
rise in serum creatinine, there was associated improvement in 
hemodynamics and a fall in proinflammatory cytokines (IL-
1β, IL-6, IL-18).
In summary, some urine biomarkers including KIM-1 and 
calbindin rose early and then showed an early fall. On the other 
hand, NGAL also rose early, but peaked later, and remained 
elevated till clinical recovery. Cell cycle arrest markers rose 
after the injury markers and fell prior to clinical recovery. 
Urine cystatin C rose later, at the same time as serum creatinine 
(24 hours), suggestive of decreased renal functionality. Urine 
MCP-1, osteopontin, and IL-18 were elevated at various points 
in the clinical course but did not demonstrate any clear pattern 
of rise and fall.
As with current clinical use, it is unclear to what extent the 
urine biomarkers reflect what is filtered from the circulation 
into the urine, as opposed to de novo production within the 
kidney. There was no correlation between paired urine and 
serum levels of IL-18, MCP-1, or cystatin C. A modest positive 
correlation was seen between urine and serum NGAL values 
(r2 = 0.713; p < 0.001), even when including septic animals 
only (r2 = 0.654; p < 0.001).
Renal Histology
The degree of injury at 24 hours was relatively mild (Fig. 5). 
Predominant findings included mild tubular dilatation and 
brush border loss. Tubular injury was patchy, among areas 
of normal histology. By comparison, histology is shown of a 
hemorrhage-reperfusion model performed in the laboratory 
in similarly aged male Wistar rats (Fig. 5B). TUNEL staining 
revealed minimal presence of cell death, with an average of two 
TUNEL positive cells per 20× magnification field. Where pres-
ent, TUNEL positive cells were within proximal tubular epithe-
lial cells (PTECs) (Fig. 5).
DISCUSSION
Our study aim was to measure temporal changes in a panel 
of AKI biomarkers measured from the onset of sepsis through 
to recovery in a long-term fluid-resuscitated model of fecal 
peritonitis. This model demonstrates many hemodynamic, 
biochemical, and immunologic features consistent with clini-
cal sepsis. As with human septic AKI, renal histology dem-
onstrated minimal structural injury or cell death; influx of 
inflammatory cells was not seen. We report novel data show-
ing an early change in markers of renal injury (urine NGAL, 
KIM-1, calbindin), followed by a marker of cell cycle arrest 
(urine IGFBP-7) and, finally, by functional markers of filtra-
tion (serum creatinine and cystatin C) (Supplemental Fig. 1, 
Supplemental Digital Content 1, http://links.lww.com/CCM/
C456). Urine NGAL was the most sensitive marker among 
those studied, rising from 3 to 24 hours. The rise of the func-
tional biomarker, serum cystatin C, at 12 hours implies a fall in 
GFR, whereas the concurrent fall in serum creatinine is sugges-
tive of decreased creatinine production.
Serum urea and creatinine were initially elevated at 3 and 
6 hours, and fell toward baseline values at 12 hours with IV 
fluid resuscitation. This is consistent with early hemoconcen-
tration followed by a dilution effect. A correction factor can 
be applied to measured serum creatinine to correct for fluid 
administration (7) as acute hemodilution may mask the creati-
nine rise in early AKI (8). However, applying a correction fac-
tor for cumulative fluid balance over periods longer than a few 
hours lacks both a physiologic rationale and objective evidence 
of accuracy (9). After a large fluid bolus that increased circu-
lating volume by 25%, 24-hour serum creatinine was only 2% 
below expected (9). The rise in serum cystatin C (consistent 
with a decrease in GFR) from 6 to 12 hours with concurrent 
falls in serum creatinine may be a consequence of decreased 
creatinine production (10). As with serum creatinine, sepsis 
decreases serum cystatin C production and increases nonrenal 
clearance (11). However, serum cystatin C had a faster rise and 
peaked more rapidly than creatinine. As such, serum cystatin 
C detects AKI early and better reflects inulin GFR in cecal liga-
tion and puncture (CLP)-induced murine sepsis.
The temporal changes in cytokine levels in our model were 
similar to a cohort study of 1,886 subjects hospitalized with 
community-acquired pneumonia (12). There was an early 
peak of both pro- and anti-inflammatory cytokines followed 
by a decline in the proinflammatory cytokine profiles and per-
sistence of the anti-inflammatory cytokine IL-10 though to 
recovery.
Food and Drug Administration–approved AKI biomark-
ers urine TIMP-2 and IGFBP-7 may be superior to NGAL in 
diagnosing AKI early in critically ill patients (13, 14). TIMP-2 
and IGFBP-7 measured early in the setting of critical illness 
may also identify patients with AKI at increased risk of mortal-
ity or receipt of renal replacement therapy in the subsequent 
9 months (15). In a CLP model of sepsis, the combination of 
TIMP-2 and IGFBP-7 has greater sensitivity in diagnosis of AKI 
compared with serum creatinine (6). However, the kinetics of 
these biomarkers in renal recovery has not been described.
 Urine IL-18 is less promising than urine NGAL in septic 
AKI (13), and we report here similar findings. Two markers 
of distal tubular injury, calbindin and osteopontin, have not 
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been previously evaluated in septic AKI. Urine calbindin was 
elevated at 6–12 hours, whereas urine osteopontin did not dif-
fer between septic and sham animals. Urine MCP-1 has also 
not been characterized in septic AKI; levels were significantly 
elevated between 12 and 18 hours.
A transient and modest, albeit statistically significant rise, 
was seen in urine osteopontin levels at 12 hours. Within the 
normal kidney, osteopontin is mainly present in the loop of 
Henlé and distal nephron (16), but in our model, proximal 
tubular injury predominated. In a renal ischemia-reperfusion 
injury model, the distribution of osteopontin in PTECs and 
distal TECs (DTECs) differed (17). While DTECs showed 
an early and persistent increase 
in osteopontin, the rise seen in 
PTECs was delayed and mostly 
associated with morphological 
regeneration. This suggests osteo-
pontin may promote recovery via 
modulation of infiltrating cells 
and local responses by the PTEC. 
Ours, we believe, is the first study 
to measure urine osteopontin in 
septic AKI.
Consistent with other studies 
in both patients and animal mod-
els (18–20), the renal histology in 
our model shows disproportion-
ately minimal parenchymal injury 
and apoptosis for the degree of 
functional impairment measured. 
There was no evidence of intersti-
tial hypercellularity at any point 
to suggest significant immune cell 
infiltration.
Our preclinical model used 
a homogenous population of 
relatively young rats receiving 
an identical insult 24 hours after 
anesthesia and instrumentation. 
Patients with sepsis have a more 
variable genetic make-up, are usu-
ally older, with coexisting comor-
bid illnesses, and are receiving 
other nephrotoxic and renal phys-
iology-modifying interventions. 
Other than hemodynamics and 
temperature, serial measurements 
were not made in the same animal 
as each time point represents the 
terminal experiment for collec-
tion of blood, renal tissue, and 
urine samples. We therefore can-
not plot the trajectory of variables 
such as urine output or recovery 
from anuria over time. As the 
most unwell animals were anuric, 
urine biomarkers could not be measured in these animals.
Despite ample fluid resuscitation and becoming febrile, the 
rats in our peritonitis model do not develop a hyperdynamic 
circulation. We have previously shown in this model that sig-
nificant myocardial depression yet maintained cardiac output 
(21). Many large animal models use an infusion of endotoxin 
or IV administration of live bacteria (rather than the more 
clinically representative fecal peritonitis insult), and these may 
produce a different circulatory/inflammatory profile.
We avoided antibiotic use in our study to avoid potential 
confounding from direct nephrotoxicity and renal impairment 
secondary to increased inflammation (22). We thus did not 
Figure 5. Histological assessment of rat kidneys (magnification ×20). A, Renal tissue without any 
significant damage. B, Renal tissue obtained from a hemorrhage-reperfusion model (Dyson et al [5]), 
showing several characteristics of acute tubular injury including dilated tubules with loss of brush border, 
ischemic glomeruli, and tubular casts. C, Kidney section from a 24-hr sham-operated rat. D, Kidney section 
from a 24-hr septic rat. E, Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) stain of 
naïve renal tissue shows two apoptotic cells per ×20 field. Apoptotic cells stain dark brown (arrow).  
F, TUNEL stain of 24-hr septic renal tissue shows occasional apoptotic cells. Apoptotic bodies seen mainly 
in proximal tubular epithelial cells (×20 magnification). Arrow = TUNEL positive cell, cast = tubular cast,  
CD = collecting duct, G = glomerulus, PT = proximal tubule.
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wish to confound the biomarker data in our study with a poten-
tial additional impact of antibiotics, which may add nephrotox-
icity. Despite the nonuse of antibiotics, 80% of rats recovered 
with fluid resuscitation only. Similar data have been reported 
by Hollenberg et al (23) in a mouse CLP model. Of note, the 
outcome effectiveness of antibiotics is age-dependent (24).
Serum creatinine in the septic animals rose by only 50%, 
less than that seen clinically. However, in this fluid-resuscitated 
model, animals with a greater than 50% rise in serum creati-
nine at 24 hours tended to not survive much longer. In pilot 
studies, the creatinine rise seen at 24 hours could be reached by 
6 hours in the absence of fluid resuscitation (data not shown). 
However, in these non-resuscitated animals, mortality rates 
were both very high and occurred much earlier, preventing 
study of the recovery phase.
Normalization to urinary creatinine concentration 
improved the prediction of developing AKI and outcome 
among critically ill patients, but provided no advantage in diag-
nosing established AKI (25). Similar findings were described in 
a rat model of drug-induced AKI (26). In this study, biomarker 
levels could not be corrected to urine creatinine concentration 
in many animals due to limited or absent urine output, par-
ticularly in the most severely affected.
We did not compare these biomarkers against other inflam-
matory, nonseptic insults, nor did we try to differentiate sys-
temic from local production of the biomarker. Because of the 
need to terminally anesthetize the animals to obtain blood, 
urine, and tissue samples, we did not monitor biomarker levels 
in the same animal over time and thus could not assess the 
ability to prognosticate for the development of AKI.
No specific intervention currently exists for septic AKI. 
Intuitively, initiating therapies early would be of greater ben-
efit, but this remains speculative. Time zero, the time of onset 
of AKI, is rarely known in patients. If the biomarker pattern 
we observed in our rat model holds true for patients, this may 
aid selection for interventions and potentially enhance the 
likelihood of therapeutic benefit. The temporal relationship of 
biomarker change described may shed some light into patho-
physiologic mechanisms.
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APPENDIX
Fecal Slurry
The batch of slurry used for the entire set of experiments was 
identical. Fecal slurry was obtained from pooled stool from 
three healthy nonvegetarian donors. Immediately after collec-
tion, material was 1:1 diluted with a thioglycolate suspension 
and catalase for optimization of bacterial growth and inacti-
vation of reactive oxygen species. Additionally, 10% glycerine 
was added and the suspension homogenized under anaero-
bic conditions. The slurry was then divided into aliquots 
and frozen at –80°C. Microbiology testing after thawing at 
different time intervals confirmed ongoing and similar bacte-
rial growth of fecal flora. On the day of the experiment, ali-
quots were thawed, diluted with n-saline (1.2 mL slurry was 
diluted with 1.8 mL n-saline [2:3 dilution factor]), and 5 mL/
kg body weight and injected intraperitoneally. The “potency” 
of fecal slurry does depend on the dilution factor. For this 
set of experiments, 1.2 mL slurry was diluted with 1.8 mL 
n-saline (2:3 dilution factor) and 5 mL/kg body weight was 
injected. A dose of 4.5–5.0 mL/kg was the LD50. The dose 
used in this set of experiments was 4 mL/kg, with a corre-
sponding 20% mortality.
